„From App to Bedside“ - Utility evaluation of Ada-symptom-analysis for detection of familial Mediterranean fever

„From App to Bedside“ - Utility evaluation of Ada-symptom-analysis for detection of familial Mediterranean fever - Appraise-Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031084

Enrollment

100

Registered

2023-03-17

Start date

2023-03-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E85.0

Interventions

Group 1: Adults with Ada-app suspected diagnosis of familial Mediterranean fever (FMF) Group 2: Adults with diagnosed FMF by a physician

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: For both groups: - Consent to participate in the research project - Signed consent to scientific data collection, data storage and data processing - Understanding of the German language Group 1: - Diagnosis of FMF suspected by Ada symptom-analysis - as well as no confirmed diagnosis of FMF yet Group 2: - Medical diagnosis of FMF within the last 5 years before inclusion in this research project

Exclusion criteria

Exclusion criteria: For both groups: - Persons incapable of giving consent

Design outcomes

Primary

Measure	Time frame
Survey of the time from the onset of initial symptoms to diagnosis and comparison of both patient groups	—

Secondary

Measure	Time frame
- Comparison of both patient groups with regard to medical diagnostic already used and number of visits by a physician regarding diagnosis FMF - Recording of the number of sick days in the last 2 years due to FMF before diagnosis and in the last year before inclusion - Calculation of the cost savings potential when implementing the app as an access authorisation for a quick specialist consultation - Physicians assessment of the benefits of Ada's pre-diagnostic assessment - Reliability of Ada's disease suggestions	—

Measure

Time frame

- Comparison of both patient groups with regard to medical diagnostic already used and number of visits by a physician regarding diagnosis FMF - Recording of the number of sick days in the last 2 years due to FMF before diagnosis and in the last year before inclusion - Calculation of the cost savings potential when implementing the app as an access authorisation for a quick specialist consultation - Physicians assessment of the benefits of Ada's pre-diagnostic assessment - Reliability of Ada's disease suggestions

—

Countries

Germany

Contacts

Public ContactRheumatologie Neue Therapien

Studienabteilung Rheumatologie - Neue Therapien

rheumastudien@charite.de+4930450513025

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026